Science & Health
Precision in the Crosshairs: India’s First Approved Radioligand Therapy for Advanced Prostate Cancer
Novartis launches Pluvicto in India, the first approved radioligand therapy for advanced prostate cancer. Learn how this precision treatment targets cancer cells.
By Arjun Mehta · 7 hours ago